SIA
BIOTU

Schechter Investment Advisors’s Biotech Acquisition Company Unit BIOTU Stock Holding History

Schechter Investment Advisors’s Portfolio BIOTU Stock Details BIOTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-34,525
Closed -$346K – 987
2021
Q4 		$346K Buy
+34,525
New +$349K 0.03% 635

Other funds holding BIOTU

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SIA
SkyView Investment Advisors Shrewsbury, New Jersey $743M AUM 17.91% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Schechter Investment Advisors's BIOTU Position: Q1 2022 in Review

Schechter Investment Advisors sold out of Biotech Acquisition Company Unit (BIOTU) in Q1 2022, closing a stake of 34,525 shares — an estimated $346K sold.

Schechter Investment Advisors first reported a position in BIOTU in Q4 2021 and held it in 1 quarter. The position peaked at $346K in Q4 2021. 10 funds tracked by Wall St. Rank hold BIOTU as of Q1 2022.

  • Schechter Investment Advisors reported no remaining Biotech Acquisition Company Unit position as of Q1 2022 after selling out during the quarter.
  • Schechter Investment Advisors sold 34,525 Biotech Acquisition Company Unit shares in Q1 2022, an estimated $346K.
  • Schechter Investment Advisors first reported a position in Biotech Acquisition Company Unit in Q4 2021 and held it in 1 quarter.
  • Schechter Investment Advisors's Biotech Acquisition Company Unit position peaked at $346K in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Biotech Acquisition Company Unit as of Q1 2022.

Based on Schechter Investment Advisors's 13F filing for Q1 2022, filed 18 Nov 2022.